Table I.
Characteristics of patients on the day of PRP administration.
| Baseline* | Group 1a | Group 2b |
|---|---|---|
| Patients (n) | 54 | 26 |
| Age (years) | 44.2 ± 5.0 | 44.1 ± 6.4 |
| Antral follicles (n) | 2.1 ± 2.1 | 1.0 ± 1.5 |
| Lead follicle (mm) | 11.4 ± 7.5 | 8.0 ± 7.0 |
| FSH (mIU/ml) | 36.6 ± 40.5 | 79.4 ± 48.2 |
| Estradiol (pg/ml) | 103.6 ± 82.1 | 64.8 ± 50.7 |
| AMH (ng/ml) | 0.27 ± 0.50 | 0.07 ± 0.20 |
| BMI (kg/m2) | 23.7 ± 4.3 | 23.6 ± 4.1 |
| Race (n/%) | ||
| Caucasian | 41 (77.4) | 21 (80.8) |
| Asian | 7 (13.0) | 3 (11.5) |
| African | 6 (11.1) | 2 (7.7) |
*
Values obtained on day of PRP treatment.
a
Group 1—DOR but still regular menstrual cycles and bGroup 2—DOR but irregular menstrual cycles or amenorrhea.
PRP, platelet rich plasma; DOR, diminished ovarian reserve.